CytoVale
PrivateLast Round
Series D
Oct 10, 2024
Est. Valuation
$32.25M
Total Funding Raised
$219.34M
Company Overview
CytoVale is a biotechnology company that develops innovative biophysical markers to enhance diagnostics through cell mechanics and machine learning, allowing for the early detection of sepsis and improved patient outcomes while reducing treatment costs.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CytoVale Comps
Public and private peers based on sector, stage, and business model.
CytoVale Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Oct 10, 2024 | ||||
| Series C | Nov 15, 2023 | ||||
| Grant | Feb 8, 2022 | ||||
| Grant | May 19, 2020 | ||||
| Debt | Oct 30, 2019 | ||||
Grant | Sep 28, 2019 |
Key People
Founding team and executive leadership
CytoVale Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pactolus Ventures | Series B |
| CPP Investments | Series D |
| Baidu Ventures | Series B |
| Dolby Family Ventures | Series A |
| IT-Farm Corporation | Series A |
| Creative Ventures | Grant |
| Norwest Venture Partners | Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
Eric Khairy appointed as the new Chief Marketing Officer.
- Mar 1, 2025
Dave Vort appointed as Chief Commercial Officer.
CytoVale Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CytoVale's valuation, stock price, and market status.
